Central Pharmaceutical Joint Stock Company No3 (HNX:DP3)
Vietnam · Delayed Price · Currency is VND 61,200
+100 (0.16%)
At close: Jul 24, 2026
HNX:DP3 Cash Flow Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 173,966 | 156,073 | 121,172 | 125,263 | 108,824 | 94,305 |
Depreciation & Amortization | 12,401 | 12,401 | 12,941 | 13,980 | - | - |
Other Amortization | 80 | 80 | - | - | - | - |
Loss (Gain) From Sale of Assets | -22,864 | -22,864 | -15,492 | -21,684 | - | - |
Other Operating Activities | -62,497 | 5,366 | -1,041 | 4,079 | -9,609 | -67,997 |
Change in Accounts Receivable | -3,296 | -3,296 | -24,076 | 13,163 | - | - |
Change in Inventory | -12,741 | -12,741 | 8,406 | 17,504 | - | - |
Change in Accounts Payable | 17,041 | 17,041 | -10,859 | -414.91 | - | - |
Change in Other Net Operating Assets | -553.55 | -553.55 | 866.97 | 1,211 | - | - |
Operating Cash Flow | 101,536 | 151,507 | 91,917 | 153,102 | 99,215 | 26,308 |
Operating Cash Flow Growth | -32.86% | 64.83% | -39.96% | 54.31% | 277.13% | -78.50% |
Capital Expenditures | -7,588 | -7,588 | -1,465 | -6,403 | -15,089 | -446.26 |
Sale of Property, Plant & Equipment | 30 | 30 | 269.41 | 1,824 | - | - |
Other Investing Activities | 22,731 | 19,994 | 16,852 | 17,521 | 8,814 | 6,324 |
Investing Cash Flow | -26,537 | -130,566 | -11,330 | -102,680 | -54,654 | 25,878 |
Short-Term Debt Issued | - | - | - | - | 15,414 | 10,210 |
Long-Term Debt Issued | - | 91,172 | 10,100 | 15,110 | - | - |
Total Debt Issued | 91,172 | 91,172 | 10,100 | 15,110 | 15,414 | 10,210 |
Short-Term Debt Repaid | - | - | - | - | -12,222 | -12,060 |
Long-Term Debt Repaid | - | -56,899 | -17,875 | -12,565 | -1,490 | - |
Total Debt Repaid | -101,201 | -56,899 | -17,875 | -12,565 | -13,712 | -12,060 |
Net Debt Issued (Repaid) | -10,029 | 34,273 | -7,775 | 2,545 | 1,702 | -1,850 |
Common Dividends Paid | -64,434 | -64,444 | -64,481 | -68,698 | -49,885 | -66,529 |
Financing Cash Flow | -74,463 | -30,171 | -72,256 | -66,153 | -48,183 | -68,379 |
Foreign Exchange Rate Adjustments | -0.91 | 0.05 | 0.27 | 0.72 | 25.84 | 2.48 |
Net Cash Flow | 535.3 | -9,231 | 8,331 | -15,731 | -3,596 | -16,191 |
Free Cash Flow | 93,947 | 143,919 | 90,452 | 146,699 | 84,126 | 25,862 |
Free Cash Flow Growth | -37.27% | 59.11% | -38.34% | 74.38% | 225.29% | -52.21% |
Free Cash Flow Margin | 18.22% | 32.86% | 21.67% | 35.80% | 17.34% | 6.79% |
Free Cash Flow Per Share | 4369.52 | 6693.91 | 4207.10 | 6823.21 | 3717.11 | 1202.91 |
Cash Interest Paid | 679.56 | 679.56 | 188.5 | 1,567 | 2,868 | 1,207 |
Cash Income Tax Paid | 31,179 | 31,179 | 31,740 | 27,665 | 24,159 | 29,399 |
Levered Free Cash Flow | 67,508 | 112,877 | 77,061 | 127,650 | 60,230 | 55,727 |
Unlevered Free Cash Flow | 68,410 | 113,311 | 77,162 | 128,646 | 64,277 | 56,008 |
Change in Working Capital | 450.61 | 450.61 | -25,662 | 31,463 | - | - |